Hepatitis Treatment
Hepatitis B and hepatitis C are different viruses with different treatment aims. Hepatitis B treatment usually manages the virus over the long term, while current hepatitis C treatment aims to clear it completely, so which medicine someone needs depends on which virus is involved.
Epivir Hbv
100mg · 150mg
Developed to mitigate active hepatitis B replication to support liver cell safety and target viral reverse transcription.
Hepcinat Lp
90mg + 400mg
Treats chronic hepatitis C virus infection by inhibiting viral replication, resulting to sustained virological response and elimination of the virus from the body.
Key points
- CDC’s Clinical Care of Hepatitis B page notes that not every person with chronic hepatitis B needs medicine, and that treatment is not considered curative.
- CDC’s Clinical Care of Hepatitis C page states that current oral antiviral therapy can cure more than 95 percent of people within eight to twelve weeks.
- CDC recommends checking hepatitis B status before starting hepatitis C treatment, because the direct-acting antivirals used for hepatitis C can let a quiet hepatitis B infection reactivate.
Chronic hepatitis B medicines
Baraclude contains entecavir and Epivir HBV contains lamivudine, both taken as tablets for chronic hepatitis B. Tenvir contains tenofovir disoproxil and is used for chronic hepatitis B as well as HIV, since the same ingredient treats either condition. None of these medicines clear the virus outright; they work by holding it in check.
Chronic hepatitis C medicines
Hepcinat LP combines ledipasvir with sofosbuvir and treats chronic hepatitis C across several genotypes, including in children from the age of three. In harder cases, such as decompensated cirrhosis or after a liver transplant, it is used alongside Copegus, which contains ribavirin, an older hepatitis C ingredient added to support treatment rather than a modern cure on its own.